On our screens:Cheap stocks by free cash flow yield
Is the price fair?
What INSP's price assumes
Inspire Medical Systems, Inc. trades at 14.1× earnings against 30.9× for the median Medical Devices name, cheaper than its own group.
14.1
Trailing P/E · Medical Devices median 30.9 · cheaper than the typical name in its group
- Price / sales
- 1.62
Price / sales · as of 2026-Q1
- Free cash flow yield
- 7.7%
Free cash flow yield · Medical Devices median 3.9%
- Growth the price implies
- −0.14%
Growth the price implies · The price pays for −0.14% free cash flow growth a year for a decade; the business has delivered +104% a year over the last three.
Details›
- Price / book2026-Q1
- 1.87
- Healthcare median P/E362 names
- 29.9
- Medical Devices median P/E39 names
- 30.9
- Free cash flow, trailing twelve months
- $97M
- Market capitalisation
- $1.25B
- 3-year revenue growth
- +25%
- 3-year free cash flow growth
- +104%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.